Double-Blind Comparison of Carbenicillin Indanyl Sodium, Ampicillin, and Cephalexin in Treatment of Urinary Tract Infection
Open Access
- 1 December 1973
- journal article
- clinical trial
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 4 (6) , 593-596
- https://doi.org/10.1128/aac.4.6.593
Abstract
Carbenicillin indanyl sodium, ampicillin, or cephalexin was administered orally to 61 patients with urinary tract infections. Assignment of drug was made by a computer-generated, randomized plan in a double-blind fashion. The rates of cure 4 weeks after therapy were 50, 42, and 50% for patients treated with carbenicillin, ampicillin, and cephalexin, respectively. Failure of therapy was correlated with chronicity of infection and sensitivity of the microorganism to the antibiotic used. Thirty-nine percent of the patients developed side effects, but there were no significant differences in side effects among the three antibiotics. This double-blind study demonstrates that carbenicillin indanyl sodium is as effective as ampicillin and cephalexin in treatment of urinary tract infections.Keywords
This publication has 3 references indexed in Scilit:
- Carbenicillin Indanyl Sodium, an Orally Active Derivative of CarbenicillinAntimicrobial Agents and Chemotherapy, 1972
- Human pharmacology and clinical evaluation of an oral carbenicillin preparationClinical Pharmacology & Therapeutics, 1971
- Evaluation of an indanyl ester of carbenicillin.1970